Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model.
about
Effects of Propofol on Respiratory Drive and Patient-ventilator Synchrony during Pressure Support Ventilation in Postoperative Patients: A Prospective Study.Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patientsComparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patientsProlonged Treatment with Propofol Transiently Impairs Proliferation but Not Survival of Rat Neural Progenitor Cells In Vitro.Recovery profile of patients undergoing nasal surgical procedures: a comparison between sevoflurane and propofolSedation in the intensive care setting.Economic evaluation of sustained sedation/analgesia in the intensive care unit.Diurnal sedative changes during intensive care: impact on liberation from mechanical ventilation and delirium.The antinociceptive and antihyperalgesic effects of topical propofol on dorsal horn neurons in the rat.Dexmedetomidine use in the ICU: are we there yet?Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study.Sedation breaks: are they good for the critically ill patient? A review.Medications for analgesia and sedation in the intensive care unit: an overviewA systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.Intensive care sedation: the past, present and the future.Approaches for dosage individualisation in critically ill patients.Persistence of Delirium after Cessation of Sedatives and Analgesics and Impact on Clinical Outcomes in Critically Ill Patients.Does Propofol Sedation Contribute to Overall Energy Provision in Mechanically Ventilated Critically Ill Adults? A Retrospective Observational Study.The pharmacokinetics of propofol in ICU patients undergoing long-term sedation.Propofol sedation using Diprifusor target-controlled infusion in adult intensive care unit patients.Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients.Delirium in Intensive Care Unit Patients: Ten Important Points of Understanding.Precision and Bias of Target-Controlled Prolonged Propofol Infusion for General Anesthesia and Sedation in Neurosurgical Patients.Of delirium and sedation.Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit.Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients.
P2860
Q33723182-A39D8C15-5442-405A-8FFC-9079B3C638C6Q33928235-C283D168-2AA2-46FE-80E6-2E46F410E56DQ34479708-210D063A-275F-491C-9CE5-FB829DB9037EQ36068185-7608BA2D-2560-467A-85D0-07220DAD1CBFQ36256985-04E63785-D995-4EDF-BBF5-7C8F30B12845Q36429872-5FB2A733-ABEE-43AB-AF41-4B641C3D0784Q36613928-0045CD66-9FE5-4BDE-A178-2B8EC4F757FFQ36621211-DA068CD3-6CA6-4CC1-B650-6D86596C5427Q36711319-AC314A53-37E1-4501-8C25-1BF3300A8DAAQ36997955-56E3D3F3-ED56-4457-A384-F6E6F62D1C0EQ37059649-A2E6F136-600B-42B9-908A-7C2469F5D296Q37090443-14F8C8FD-C89D-492D-AD26-D2095DB83395Q37169834-6634258C-140A-417F-A432-9D5D8A3F18FAQ38012111-185BAF5E-8DC2-4EB2-A532-44DC97BE95DAQ38113860-CE53229E-6889-4F52-8BD2-A654282F56B4Q38125209-1C2857F3-7FDF-4987-8BD0-C6E20FD54573Q38605997-50F472FB-A621-4AD7-8789-D593F1DB46CEQ38628760-FA1E14B2-CE79-47F1-9C12-7486887D02DAQ39457828-01E25FA4-35E2-4DE1-9237-9A31E102A394Q44939205-604D8392-B13A-444C-8992-61CABDC6110AQ46721363-2C71A526-A1A0-4A17-B7DB-AA342817D50BQ47118396-CB53DEC6-27A8-4E9A-BD8C-34F0508AD9E5Q47213786-49340BDE-566F-4176-9038-E704771623CDQ47899226-D368C778-C2F4-4A0F-9504-0BF4424B3E28Q47925153-4CF26200-C39A-429A-B5ED-F7A9E9F6D744Q48575819-A4544FD0-B838-4577-B2C7-ECC26C649252
P2860
Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@ast
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@en
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@nl
type
label
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@ast
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@en
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@nl
prefLabel
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@ast
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@en
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@nl
P2093
P1433
P1476
Propofol dosing regimens for I ...... kinetic-pharmacodynamic model.
@en
P2093
Sandoval NF
Zomorodi K
P304
P356
10.1097/00000542-200108000-00011
P407
P577
2001-08-01T00:00:00Z